@inproceedings{inproceedings, title = {{MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/j.jtho.2023.09.154 }}, year = {{2023}}, month = {{11}}, author = {{Middleton G and Fletcher P and Savage J and Mehmi M and Greystoke A and Dangoor A and Cave J and Escriu C and Shaw P and Steele N and Jain P et al}}, doi = {{10.1016/j.jtho.2023.09.154}}, volume = {{18}}, journal = {{Journal of Thoracic Oncology}}, issue = {{11}}, pages = {{S119-S120}}, note = {{Accessed on 2025/09/06}}}